Zydus Cadila gets USFDA approval for deferasirox tablets
Deferasirox binds to iron and removes it from the bloodstream. It is used to treat iron overload caused by blood transfusions in adults and children who are at least 2 years old.
Indication of drug
It is also used to treat chronic iron overload syndrome caused by a genetic blood disorder (non-transfusion dependent thalassemia) in adults and children who are at least 10 years old. The drug will be manufactured at the group’s manufacturing facility at SEZ, Ahmedabad.
The group now has 289 approvals and has so far filed over 386 ANDAs since the commencement of the filing process in FY 2003-04.